Quest Diagnostics Inc Equity Method Investments
Quest Diagnostics Inc (DGX) had Equity Method Investments of $137.00 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:EquityMethodInvestments · last filed 2026-07-23
- 2026-06-30: Equity Method Investments $137.00M.
- 2026-03-31: Equity Method Investments $134.00M.
- 2025-12-31: Equity Method Investments $136.00M.
- 2025-09-30: Equity Method Investments $137.00M.
| Period end | Equity Method Investments | Equity Method Investments as first filed |
|---|---|---|
| 2026-06-30 | $137.00M 10-Q · filed 2026-07-23 | |
| 2026-03-31 | $134.00M 10-Q · filed 2026-04-22 | |
| 2025-12-31 | $136.00M 10-Q · filed 2026-07-23 | |
| 2025-09-30 | $137.00M 10-Q · filed 2025-10-21 | |
| 2025-06-30 | $136.00M 10-Q · filed 2025-07-23 | |
| 2025-03-31 | $134.00M 10-Q · filed 2025-04-23 | |
| 2024-12-31 | $123.00M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $125.00M 10-Q · filed 2024-10-23 | |
| 2024-06-30 | $126.00M 10-Q · filed 2024-07-24 | |
| 2024-03-31 | $133.00M 10-Q · filed 2024-04-24 | |
| 2023-12-31 | $135.00M 10-K · filed 2025-02-20 | |
| 2023-09-30 | $130.00M 10-Q · filed 2023-10-25 | |
| 2023-06-30 | $135.00M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $128.00M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $132.00M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $138.00M 10-Q · filed 2022-10-21 | |
| 2022-06-30 | $147.00M 10-Q · filed 2022-07-22 | |
| 2022-03-31 | $155.00M 10-Q · filed 2022-04-22 | |
| 2021-12-31 | $141.00M 10-K · filed 2023-02-21 | |
| 2021-09-30 | $124.00M 10-Q · filed 2021-10-22 | |
| 2021-06-30 | $111.00M 10-Q · filed 2021-07-23 | |
| 2021-03-31 | $527.00M 10-Q · filed 2021-04-23 | |
| 2020-12-31 | $521.00M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $480.00M 10-Q · filed 2020-10-23 | |
| 2020-06-30 | $495.00M 10-Q · filed 2020-07-24 | |
| 2020-03-31 | $496.00M 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $482.00M 10-K · filed 2021-02-22 | |
| 2019-09-30 | $474.00M 10-Q · filed 2019-10-23 | |
| 2019-06-30 | $458.00M 10-Q · filed 2019-07-24 | |
| 2019-03-31 | $454.00M 10-Q · filed 2019-04-24 | |
| 2018-12-31 | $436.00M 10-K · filed 2020-02-20 | |
| 2018-09-30 | $456.00M 10-Q · filed 2018-10-24 | |
| 2018-06-30 | $456.00M 10-Q · filed 2018-07-25 | |
| 2018-03-31 | $474.00M 10-Q · filed 2018-04-20 | |
| 2017-12-31 | $462.00M 10-K · filed 2019-02-21 | |
| 2017-09-30 | $459.00M 10-Q · filed 2017-10-19 | |
| 2017-06-30 | $451.00M 10-Q · filed 2017-07-25 | |
| 2017-03-31 | $443.00M 10-Q · filed 2017-04-21 | |
| 2016-12-31 | $443.00M 10-K · filed 2018-02-23 | |
| 2016-09-30 | $452.00M 10-Q · filed 2016-10-21 | |
| 2016-06-30 | $453.00M 10-Q · filed 2016-07-25 | |
| 2016-03-31 | $471.00M 10-Q · filed 2016-04-27 | |
| 2015-12-31 | $473.00M 10-K · filed 2017-02-22 | |
| 2015-09-30 | $478.00M 10-Q · filed 2015-10-29 | |
| 2014-12-31 | $46.00M 10-K · filed 2016-02-26 | |
| 2013-12-31 | $45.00M 10-K · filed 2015-02-24 | |
| 2012-12-31 | $46.00M 10-K · filed 2014-02-18 | $45.66M 10-K · filed 2013-02-27 |
| 2011-12-31 | $45.02M 10-K · filed 2013-02-27 | $45.00M 10-K · filed 2012-02-16 |
| 2010-12-31 | $45.00M 10-K · filed 2012-02-16 | $44.90M 10-K · filed 2011-02-16 |
| 2009-12-31 | $46.30M 10-K · filed 2011-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |